VTX2735 Clinical Trials (2026): 2 Studies for Cryopyrin Associated Periodic Syndrome & Recurrent Pericarditis
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
2 VTX2735 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Cryopyrin Associated Periodic Syndrome & Recurrent Pericarditis) and 57 total planned enrollment. 1 VTX2735 clinical trial is actively recruiting at 13 U.S. sites across 11 states. Most recent activity: NCT06836232 (Oct 2027).
Where to Participate: All VTX2735 Trial Sites in the U.S. (13 sites across 11 states)
Every actively recruiting VTX2735trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | University of California Irvine Medical Center | Orange92868 | NCT06836232 | Map |
| FL | Flourish Research - St. Augustine - PPDS | Saint Augustine32086 | NCT06836232 | Map |
| IL | Bluhm Cardiovascular Institute of Northwestern | Chicago60611 | NCT06836232 | Map |
| MA | MGH Heart Failure and Cardiac Transplant Center Corrigan Minehan Heart Center | Boston02114 | NCT06836232 | Map |
| MN | Mayo Clinic | Rochester55905-0002 | NCT06836232 | Map |
| NY | Columbia University Irving Medical Center | New York10032 | NCT06836232 | Map |
| OH | The Cleveland Clinic Foundation | Cleveland44195 | NCT06836232 | Map |
| TX | Houston Methodist Hospital | Houston77030 | NCT06836232 | Map |
| TX | Orion Medical | Houston77034 | NCT06836232 | Map |
| UT | University of Utah | Salt Lake City84132 | NCT06836232 | Map |
| VA | University of Virginia Health System Advanced Heart Failure and Transplant Center | Richmond23298 | NCT06836232 | Map |
| VA | VCU North Hospital | Richmond23298 | NCT06836232 | Map |
| WA | Seattle Children's Hospital | Seattle98105 | NCT06836232 | Map |
VTX2735 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | completed | Total |
|---|---|---|---|
| P2 | 1 | 1 | 2 |
Recruiting VTX2735 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT06836232 | An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis | P2 | Recurrent Pericarditis | 50 | Jan 2025 |
VTX2735 clinical trials by indication
Recurrent Pericarditis (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06836232 | — | P2 | recruiting | An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis |
Cryopyrin Associated Periodic Syndrome (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05812781 | Explore | P2 | completed | A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome |
VTX2735 pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| Explore | NCT05812781 | P2 | completed | Cryopyrin Associated Periodic Syndrome | 7 | — |
All VTX2735 trials (2)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT06836232 | An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis | P2 | recruiting | 50 | Zomagen Biosciences Ltd. | Jan 2025 | |
| NCT05812781 | Explore | A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome | P2 | completed | 7 | Zomagen Biosciences Ltd. | Mar 2023 |
VTX2735 clinical trials: frequently asked questions
- How many VTX2735 clinical trials are there?
- 2 VTX2735 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 1 is marked completed.
- Are VTX2735 clinical trials recruiting in 2026?
- Yes — 1 VTX2735 trial is actively recruiting in 2026, with 13 U.S. sites across 11 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is VTX2735 being studied for?
- VTX2735 is being studied for Cryopyrin Associated Periodic Syndrome, Recurrent Pericarditis. The trials are grouped by indication on this page.
- What phase is VTX2735 in?
- VTX2735 clinical trials span 2 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors VTX2735 clinical trials?
- The lead sponsor across the most VTX2735 trials is Zomagen Biosciences Ltd.. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming VTX2735as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: